Aspect Biosystems

Tamer Mohamed, Founder and CEO

April 12 | 12:00pm | Dark Horse Consulting Ballroom 

Vancouver, Canada


Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease. Aspect is applying its full-stack tissue therapeutic platform, including proprietary microfluidic 3D bioprinting technology, computational design, therapeutic cells, and materials science, to create a pipeline of allogeneic bioprinted tissues that replace or repair damaged organ functions. These tissue therapeutics are rationally engineered to be biologically functional, immune-protective, and suitable for surgical implantation.

By using this website you agree to accept our Privacy Policy and Terms & Conditions